GRAIL INC (GRAL) Fundamental Analysis & Valuation

NASDAQ:GRAL • US3847471014

Current stock price

48.41 USD
+1.04 (+2.2%)
At close:
48.27 USD
-0.14 (-0.29%)
Pre-Market:

This GRAL fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

2

1. GRAL Profitability Analysis

1.1 Basic Checks

  • GRAL had negative earnings in the past year.
  • GRAL had a negative operating cash flow in the past year.
  • In the past 5 years GRAL always reported negative net income.
  • GRAL had a negative operating cash flow in each of the past 5 years.
GRAL Yearly Net Income VS EBIT VS OCF VS FCFGRAL Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2021 2022 2023 2024 2025 -1B -2B -3B -4B -5B

1.2 Ratios

  • Looking at the Return On Assets, with a value of -15.62%, GRAL is in the better half of the industry, outperforming 79.15% of the companies in the same industry.
  • Looking at the Return On Equity, with a value of -18.14%, GRAL belongs to the top of the industry, outperforming 83.98% of the companies in the same industry.
Industry RankSector Rank
ROA -15.62%
ROE -18.14%
ROIC N/A
ROA(3y)-39.79%
ROA(5y)-48.3%
ROE(3y)-45.67%
ROE(5y)-53.29%
ROIC(3y)N/A
ROIC(5y)N/A
GRAL Yearly ROA, ROE, ROICGRAL Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2021 2022 2023 2024 2025 -20 -40 -60 -80 -100

1.3 Margins

  • Looking at the Gross Margin, with a value of 46.88%, GRAL is in the better half of the industry, outperforming 74.52% of the companies in the same industry.
  • In the last couple of years the Gross Margin of GRAL has grown nicely.
  • GRAL does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 46.88%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y15.56%
GM growth 5YN/A
GRAL Yearly Profit, Operating, Gross MarginsGRAL Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2021 2022 2023 2024 2025 0 -2K -4K -6K -8K

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

7

2. GRAL Health Analysis

2.1 Basic Checks

  • GRAL does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • The number of shares outstanding for GRAL has been increased compared to 1 year ago.
  • GRAL has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
GRAL Yearly Shares OutstandingGRAL Yearly Shares OutstandingYearly Shares Outstanding 2019 2021 2022 2023 2024 2025 20M 40M 60M 80M 100M
GRAL Yearly Total Debt VS Total AssetsGRAL Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2021 2022 2023 2024 2025 2B 4B 6B 8B

2.2 Solvency

  • GRAL has an Altman-Z score of -2.60. This is a bad value and indicates that GRAL is not financially healthy and even has some risk of bankruptcy.
  • Looking at the Altman-Z score, with a value of -2.60, GRAL is in line with its industry, outperforming 46.72% of the companies in the same industry.
  • GRAL has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z -2.6
ROIC/WACCN/A
WACC8.84%
GRAL Yearly LT Debt VS Equity VS FCFGRAL Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2021 2022 2023 2024 2025 0 2B 4B 6B 8B

2.3 Liquidity

  • GRAL has a Current Ratio of 7.61. This indicates that GRAL is financially healthy and has no problem in meeting its short term obligations.
  • Looking at the Current ratio, with a value of 7.61, GRAL is in the better half of the industry, outperforming 71.04% of the companies in the same industry.
  • A Quick Ratio of 7.61 indicates that GRAL has no problem at all paying its short term obligations.
  • The Quick ratio of GRAL (7.61) is better than 71.04% of its industry peers.
Industry RankSector Rank
Current Ratio 7.61
Quick Ratio 7.61
GRAL Yearly Current Assets VS Current LiabilitesGRAL Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2021 2022 2023 2024 2025 200M 400M 600M 800M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

6

3. GRAL Growth Analysis

3.1 Past

  • The Earnings Per Share has grown by an impressive 83.10% over the past year.
  • GRAL shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 17.18%.
  • The Revenue has been growing by 38.37% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)83.1%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%16.15%
Revenue 1Y (TTM)17.18%
Revenue growth 3Y38.37%
Revenue growth 5YN/A
Sales Q2Q%13.97%

3.2 Future

  • GRAL is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 7.42% yearly.
  • Based on estimates for the next years, GRAL will show a very strong growth in Revenue. The Revenue will grow by 26.67% on average per year.
EPS Next Y-0.16%
EPS Next 2Y1.71%
EPS Next 3Y2.39%
EPS Next 5Y7.42%
Revenue Next Year23.93%
Revenue Next 2Y24.2%
Revenue Next 3Y25.8%
Revenue Next 5Y26.67%

3.3 Evolution

  • Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
GRAL Yearly Revenue VS EstimatesGRAL Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033 500M 1B 1.5B
GRAL Yearly EPS VS EstimatesGRAL Yearly EPS VS EstimatesYearly EPS VS Estimates 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033 0 -20 -40 -60

More info and screens

Find the best growth stocksShow best growing peers

0

4. GRAL Valuation Analysis

4.1 Price/Earnings Ratio

  • GRAL reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
  • Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for GRAL. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
GRAL Price Earnings VS Forward Price EarningsGRAL Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
GRAL Per share dataGRAL EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 40

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y1.71%
EPS Next 3Y2.39%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. GRAL Dividend Analysis

5.1 Amount

  • No dividends for GRAL!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

GRAL Fundamentals: All Metrics, Ratios and Statistics

GRAIL INC

NASDAQ:GRAL (3/18/2026, 8:12:25 PM)

Premarket: 48.27 -0.14 (-0.29%)

48.41

+1.04 (+2.2%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)02-19
Earnings (Next)05-11
Inst Owners74.93%
Inst Owner Change16.81%
Ins Owners1%
Ins Owner Change-22.18%
Market Cap1.95B
Revenue(TTM)147.17M
Net Income(TTM)-406.24M
Analysts80
Price Target95.06 (96.36%)
Short Float %16.42%
Short Ratio4.53
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)22.02%
Min EPS beat(2)12.61%
Max EPS beat(2)31.44%
EPS beat(4)4
Avg EPS beat(4)28.15%
Min EPS beat(4)12.61%
Max EPS beat(4)42.64%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)-3.5%
Min Revenue beat(2)-7.24%
Max Revenue beat(2)0.24%
Revenue beat(4)2
Avg Revenue beat(4)-2.33%
Min Revenue beat(4)-11.33%
Max Revenue beat(4)9.02%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-11.24%
PT rev (3m)-11.24%
EPS NQ rev (1m)13.27%
EPS NQ rev (3m)16.57%
EPS NY rev (1m)3.85%
EPS NY rev (3m)4.85%
Revenue NQ rev (1m)0.41%
Revenue NQ rev (3m)3.59%
Revenue NY rev (1m)3.65%
Revenue NY rev (3m)5.47%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 13.77
P/FCF N/A
P/OCF N/A
P/B 0.87
P/tB 5.5
EV/EBITDA N/A
EPS(TTM)-11.17
EYN/A
EPS(NY)-11.19
Fwd EYN/A
FCF(TTM)-8.18
FCFYN/A
OCF(TTM)-8.15
OCFYN/A
SpS3.52
BVpS55.54
TBVpS8.8
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -15.62%
ROE -18.14%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 46.88%
FCFM N/A
ROA(3y)-39.79%
ROA(5y)-48.3%
ROE(3y)-45.67%
ROE(5y)-53.29%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y15.56%
GM growth 5YN/A
F-Score4
Asset Turnover0.05
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 0.71%
Cap/Sales 0.79%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 7.61
Quick Ratio 7.61
Altman-Z -2.6
F-Score4
WACC8.84%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)83.1%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%16.15%
EPS Next Y-0.16%
EPS Next 2Y1.71%
EPS Next 3Y2.39%
EPS Next 5Y7.42%
Revenue 1Y (TTM)17.18%
Revenue growth 3Y38.37%
Revenue growth 5YN/A
Sales Q2Q%13.97%
Revenue Next Year23.93%
Revenue Next 2Y24.2%
Revenue Next 3Y25.8%
Revenue Next 5Y26.67%
EBIT growth 1Y61.72%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year37.71%
EBIT Next 3Y11.01%
EBIT Next 5Y7.77%
FCF growth 1YN/A
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1YN/A
OCF growth 3YN/A
OCF growth 5YN/A

GRAIL INC / GRAL Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for GRAIL INC?

ChartMill assigns a fundamental rating of 4 / 10 to GRAL.


Can you provide the valuation status for GRAIL INC?

ChartMill assigns a valuation rating of 0 / 10 to GRAIL INC (GRAL). This can be considered as Overvalued.


How profitable is GRAIL INC (GRAL) stock?

GRAIL INC (GRAL) has a profitability rating of 2 / 10.


What is the earnings growth outlook for GRAIL INC?

The Earnings per Share (EPS) of GRAIL INC (GRAL) is expected to decline by -0.16% in the next year.